Page last updated: 2024-08-24

meglumine antimoniate and Obesity

meglumine antimoniate has been researched along with Obesity in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Carvalho, AM; Carvalho, EM; Carvalho, LP; Castellucci, L; GuimarĂ£es, LH; Lago, A; Lago, J; Lago, T; Nascimento, M1

Other Studies

1 other study(ies) available for meglumine antimoniate and Obesity

ArticleYear
Influence of Obesity on Clinical Manifestations and Response to Therapy in Cutaneous Leishmaniasis Caused by Leishmania braziliensis.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2021, 09-15, Volume: 73, Issue:6

    Topics: Antiprotozoal Agents; Humans; Leishmania braziliensis; Leishmaniasis, Cutaneous; Meglumine Antimoniate; Obesity

2021